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Abstract
Background: There is hardly evidence on maintenance treatment with antidepressants in primary care. Nevertheless,
depression guidelines recommend maintenance treatment i.e. treatment to prevent recurrences, in patients with high risk
of recurrence, and many patients use maintenance treatment with antidepressants. This study explores the characteristics of
patients on maintenance treatment with antidepressants in general practice, and compares these characteristics with
guideline recommendations for maintenance treatment.
Methods: We used data (baseline, two-year and four-year follow-up) of primary care respondents with remitted depressive
disorder ($6 months) from the Netherlands Study of Depression and Anxiety (n = 776). Maintenance treatment was defined
as the use of an antidepressant for$12 months. Multilevel logistic regression was used to describe the association between
sociodemographic, clinical and care characteristics and use of maintenance treatment with antidepressants.
Results: Older patients, patients with a lower education, those using benzodiazepines or receiving psychological/psychiatric
care and patients with a concurrent history of a dysthymic or anxiety disorder more often received maintenance treatment
with antidepressants.
Limitations: Measurements were not made at the start of an episode, but at predetermined points in time. Diagnoses were
based on interview (CIDI) data and could therefore in some cases have been different from the GP diagnosis.
Conclusions: Since patients with chronic or recurrent depression do not use maintenance treatment with antidepressants
more often, characteristics of patients on maintenance treatment do not fully correspond with guideline recommendations.
However, patients on maintenance treatment appear to be those with more severe disorder and/or more comorbidity.
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Introduction
Depression is a common condition that has a chronic or
recurrent course in a significant proportion of cases [1]. Most
patients are treated in primary care [2,3]. Treatment in primary
care may consist of counselling by the general practitioner, various
forms of psychotherapy and/or antidepressants [4]. Many studies
have provided evidence for continuation of antidepressants after
remission to prevent relapses. Far less evidence is available for
treatment after this continuation phase, to prevent recurrences,
known as maintenance treatment [5,6]. Most guidelines do
recommend maintenance treatment, of various durations, in a
subgroup of patients with high risk of recurrence. However, the
various guidelines, such as the NICE guideline depression in
adults, the ICSI Health Care guideline major depression in adults
in primary care and the Dutch General practitioners guideline
depression (NHG-standaard Depressieve stoornis) use different
indicators for patients at increased risk of recurrence [5,7–11].
Almost all guidelines recommend maintenance treatment with
antidepressants in case of recurrent depression, some also after a
first episode if it was a severe or chronic episode. Less frequently
the following criteria are used in some guidelines: residual
symptoms, stressors or lack of support, concurrent other DSM-
IV axis I or II disorders, age ,30 or .65, rapid relapse or
recurrence in the past and family history of major depressive
disorder [5].
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In a previous paper based on data from the Netherlands Study
on Depression and Anxiety (NESDA), we reported that only 5.5%
of patients receiving antidepressants in Dutch primary care, do use
their antidepressant without a justified indication according to the
primary care guidelines depression and anxiety [12]. In the same
study we found that over half of the patients without a current
justification had started to use antidepressants with a justification
in the past. Apparently, a proportion of patients using antidepres-
sants, decide to continue them for years after recovery.
Currently, we do not know which of these patients should
indeed be advised to continue using their antidepressant to prevent
recurrences and which patients could ‘‘safely’’ be advised to
discontinue them. Studying the patients of our previous study in
more detail may shed some light on current practice in
maintenance antidepressant prescription, which patients or for
which patients the decision is made to continue antidepressant
medication? More specifically, we were interested to know
whether patients using antidepressants as maintenance treatment
have ‘valid’ reasons for that according to guideline recommenda-
tions. Therefore, we decided to compare sociodemographic,
clinical and care characteristics of remitted patients (in remission
for at least six months) with and without maintenance treatment
(antidepressant use $12 months). Subsequently we compared
these characteristics with guideline recommendations for mainte-
nance treatment. We hypothesized a priori that most patients on
maintenance treatment would meet one or more guideline criteria
(Dutch primary care guideline depression 2003) for maintenance
treatment such as a recurrent or chronic depression and that these
patients more often would have a comorbid anxiety disorder than
patients without maintenance treatment.
Materials and Methods
This study was conducted with data from NESDA (www.nesda.
nl), a large prospective cohort study (n = 2981) on the course of
depression and anxiety disorders among respondents aged 18–65
years, recruited from the community, primary care and secondary
mental health care. Detailed information on the objectives, study
population and methods of NESDA has been published [13].
Study sample
The current study used data from the baseline, two-year and
four-year follow-up measurements/interviews of NESDA on only
respondents recruited from primary care. We decided to use data
on these respondents only since we wanted a representative
primary care sample. Recruitment was described in detail
elsewhere [13]. Briefly, recruitment in primary care went as
follows. A written screener was sent to 23.750 primary care
patients that consulted their general practitioner in the past four
months, irrespective of the reason for consultation. The screener
was returned by 10,706 persons (45%). The non-responders
showed no bias with regard to psychopathology [14]. Those
screening positive were approached for a telephone interview
consisting of the Composite International Diagnostic Interview
Short Form sections (CIDI-SF), which has proven diagnostic
quality for screening purposes [15,16]. Respondents fulfilling
criteria for a current disorder on the CIDI-SF were invited to
participate, as were a random selection of screen-negatives, both
from the written screener and the CIDI-SF. In total, 1610 persons
were recruited, who underwent an extensive baseline interview,
including the CIDI [17,18]. The GP was not aware of the results
of the screening or the interview. After two years and after four
years the interview, including the CIDI was repeated.
We included those patients that had recovered from a major
depressive disorder at least more than 6 months ago according to
the CIDI at that moment (either baseline interview, two-year
follow-up or four-year follow-up), i.e. those with a lifetime major
depressive disorder but not in the past 6 months (n = 776). Some
patients fulfilled the criteria for inclusion on multiple occasions e.g.
at baseline and two-year follow-up. We included them separately
for each interview moment. In total we had 1571 observations of
remitted depression. Not all patients met criteria for remission (.6
months) on all time points. A few patients dropped out after
baseline or two-year follow-up, thereby lacking data on subsequent
interviews. In most cases not fulfilling criteria for remission was the
cause of being not included at that measurement.
Definition of maintenance treatment and other
long-term treatment
All depression guidelines mentioned in the introduction
recommend continuation treatment with antidepressants, after
having achieved remission with an antidepressant, to prevent
relapses. The recommended duration for continuation treatment
varies between four and twelve months. Maintenance treatment is
defined as all treatment with antidepressants beyond this period.
Therefore, in our analysis we defined maintenance treatment as all
treatment with antidepressants $12 months in patients with
depression that had been in remission for at least six months. With
short-term use we refer to all use of antidepressants for less than 12
months.
Determinants of maintenance use
A detailed description of all measures applied in NESDA has
been published [13]. All characteristics were measured at each
interview.
Sociodemographic characteristics. Sociodemographic
characteristics including age, gender and education were self-
reported by the patient during the interview, work status was
assessed with the Trimbos/iMTA questionnaire for assessment of
Costs associated with Psychiatric illness [19–21].
Clinical characteristics. Clinical characteristics including
current and past (last 6 months, last year, lifetime) diagnoses of
MDD and dysthymia, comorbid anxiety disorders (panic disorder
with and without agoraphobia, agoraphobia, social phobia and
generalised anxiety disorder) were all assessed with the CIDI and
severity of depression with the IDS (Inventory of Depressive
Symptomatology) and of anxiety with the BAI (Becks Anxiety
Inventory) [22,23]. The presence of suicide attempts in the past
was measured with the Beck Suicide Ideation Scale [24].
Chronic depression, defined as a CIDI diagnosis of depression
and symptoms of depression for more than 24 months and
recurrent depression defined as more than one episode of MDD in
the past, were assessed during the interviews using the CIDI and
life chart data. The life chart is a method for recalling depressive
or anxious symptomatology, the respondent was asked during the
interview to mention several important (personal) events from the
last several years and was subsequently asked to recall if there was
some depressive (or anxious) symptomatology at that point. The
life chart has been proven useful to assess course of illness in
patients with mood disorders [25–27].
Personality traits (neuroticism and extraversion) were assessed
with the Neuroticism-Extraversion-Openness-Five-Factor-Inven-
tory (NEO-FFI). The number of chronic somatic diseases was
derived from the Trimbos/iMTA questionnaire for assessment of
Costs associated with Psychiatric illness [19–21].
Care characteristics. During the interviews the respondents
were asked if they had had contact with the GP in the last six
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months, the number of contacts with the GP in the last six months,
if any of these contacts with the GP had been about mental
problems, the type of help they received (information, a referral to
a specialist/mental health care professional, psychotherapy,
practical support, skills-training, other help or no help), if they
had perceived need for more or any other form of treatment and if
they had had contact with primary (social worker, social
psychiatric nurse, first line psychologist, psychotherapist) or
secondary (psychiatrist, professional from a mental health care
organisation) mental health care.
The respondents had been asked to bring all medication they
had used in the past month to the interview. The use of
antidepressants and benzodiazepines was then recorded by the
interviewer according to the World Health Organization Ana-
tomical Therapeutic chemical (ATC) classification. 35.3% of all
respondents had forgotten to bring their medication; antidepres-
sant use was based on self-report in these subjects. Use of
antidepressants included selective serotonin reuptake inhibitors
(ATC-code N06AB), tricyclic antidepressants (N06AA) and other
antidepressants (N06AF/N06AX). St. John’s wort was not
considered an antidepressant. Past use of antidepressants and
duration of use of currently used antidepressants was based on self-
report.
Ethical considerations
The study protocol of NESDA was approved centrally by the
Ethical Review Board of the VU University Medical Center and
subsequently by local review boards of each participating center
(Univsersity Medical Center Groningen, Leiden University Med-
ical Center). After full verbal and written information about the
study, written informed consent was obtained from all participants
at the start of baseline assessment. A full ethics statement of
NESDA is found elsewhere.
Statistical methods
The Statistical Package for the Social Sciences version 20.0 for
Mac was used for the descriptive statistics to describe the study
population (IBM Statistics, Chicago, USA). The definition
‘‘maintenance antidepressant treatment’’ as described above was
used as the dependent variable. We chose to dichotomize this
outcome variable (maintenance antidepressant use; n= 271 versus
no antidepressant use or acute/continuation antidepressant use
n= 1300) since a dichotomous outcome measure simplifies
interpretation of the results and enabled us to calculate chances
in terms of percentages on patient level in the final prediction
model.
The prediction of all independent variables on our dependent
variable ‘‘maintenance antidepressant treatment’’ were analysed
with bivariate multilevel logistic regression. To prevent multi-
collinearity, we excluded from these one of each pair of continuous
variables with a mutual correlation .0.7 and dichotomous
variables with #5.0% of respondents in one of the categories.
To determine which variables independently predicted main-
tenance treatment or other long-term treatment logistic multilevel
analysis was conducted using MLwiN 2.25. Multilevel models are
hierarchical systems that estimate regression coefficients and their
variance components while at the same time correct for the
dependency of the repeated measurements (baseline, two-year and
four-year follow-up measurements). The first level was defined as
observation (within patient), the second level as patient (between
patients). The outcome variables represented the logit of the
probability (i.e. natural log of the odds) of maintenance
antidepressant treatment of depression. Regression coefficients
were transformed into odds ratios by taking the EXP[regression
coefficient]. The Wald test was used to obtain a p value for each
regression coefficient. The Wald test was also used on the variance
parameters to obtain an indication of the necessity for allowing a
random intercept or regression coefficient into the model [28].
Based on a stepwise backward selection procedure, a final model
was fitted consisting of only significant factors that constituted the
predictors for long-term/maintenance treatment with antidepres-
sants in the present study.
Results
Study sample
The first column of Table 1 lists the characteristics of the study
sample. Several dichotomous characteristics had #5% in one
category and were excluded and not listed in this table (the use of a
tricyclic or other antidepressant, whether the respondent had
received skills-training, practical support, other help or no help
and long-term use of antidepressants in the past).
Antidepressant and long-term antidepressant use
Out of 1610 primary care respondents, 776 had remitted
depression (lifetime MDD and no depression in the past six
months), these respondents had a total of 1571 measurements of
remitted depression. 1259 times no antidepressant was used, in 41
occasions an antidepressant was currently used for less than 12
months and 271 cases there was maintenance treatment with
antidepressants (antidepressant use $12 months).
The characteristics of each of these three groups are listed in the
right three columns of table 1. As the group of currently acute/
continuation users of antidepressants is very small, we compared
maintenance users with the ‘‘no antidepressant use’’ and ‘‘acute/
continuation use’’ group combined.
Determinants of maintenance antidepressant use in
remitted patients
Bivariate analysis. After excluding variables with a mutual
correlation .0.7 (received psychotherapy because of correlation
with psychological/psychiatric care) and exclusion of the variable
current SSRI use (this variable would obscure results as most
antidepressants users used an SSRI and almost all antidepressant
users were maintenance users), we did a bivariate multilevel
logistic regression (table 2). Eight variables were significantly (p,
0.05) associated with maintenance treatment with antidepressants.
Sociodemographic characteristics. Increasing age led to
more maintenance treatment, while a high education decreased
the chances for maintenance treatment with antidepressants.
Personality characteristics were also associated with maintenance
treatment with antidepressants. Increasing extraversion led to less
maintenance treatment.
Clinical characteristics. A history of anxiety disorders or
dysthymia also led to more maintenance treatment, as did a
chronic depression in the past. Recurrent depression was not
significant.
Care characteristics. Receiving care from a mental health
professional (psychological or psychiatric care) led to increased
chance of maintenance treatment with antidepressants. Finally the
use of benzodiazepines increased the ‘risk’ of receiving mainte-
nance treatment with antidepressants. Contact with the GP
whether or not about mental problems did not reach significance.
Also receiving information or a referral to a specialist remained
non-significant.
Multivariate analysis. Next, multivariate multilevel logistic
regression was performed (table 3). For multivariate analysis, we
included all characteristics from the bivariate analyses with p,0.2.
Maintenance Use of Antidepressants
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Six variables were retained in the final multivariate model. Age (in
years), education (0 = low-intermediate, 1 = high), having a history
of dysthymic disorder or an anxiety disorder (0 = no, 1= yes),
having received psychological or psychiatric care in the past six
months and the current use of benzodiazepines (0 = no, 1 = yes).
Discussion
Summary of main findings
Several characteristics of the patient, disease and treatment
were associated with maintenance use of antidepressants in
remitted depressed patients. Remarkably, both recurrent depres-
sion and chronic depression were not, this hypothesis was rejected.
Our other hypothesis that patients with a comorbid anxiety
disorder would more often be on maintenance treatment with
antidepressants was confirmed. A dysthymic disorder in previous
history had the same effect, which was unexpected since acute
treatment with antidepressants in this disorder is not first step
treatment and should be considered as a trial. It could be that GPs
view dysthymic disorder as a mild chronic depression, or that these
patients are reluctant to stop their antidepressant because of
frequent relapses. Older patients and those with a low or
intermediate education more often had maintenance treatment
with antidepressants. We think that older patients less often ‘ask’
their GP or another physician if a certain medication can be










Age in years, mean (SD) 48.1 (11.8) 47.5 (12.1) 45.2 (9.6) 51.3 (9.5)
Gender (female) 1136 (72.3%) 912 (72.3%) 30 (73.2%) 195 (72.0%)
Education (high)1 700 (44.6%) 598 (47.4%) 16 (39.0%) 88 (32.5%)
Working 1014 (64.5%) 823 (65.3%) 25 (61.0%) 168 (62.0%)
Clinical characteristics
No. chronic somatic diseases, mean (SD) 0.9 (1.1) 0.9 (1.0) 1.0 (1.2) 1.0 (1.2)
IDS2 (moderate-very severe) 272 (17.3%) 198 (15.7%) 15 (36.6%) 60 (22.1%)
BAI3 (moderate-severe) 174 (11.1%) 126 (10.0%) 8 (19.5%) 40 (14.8%)
Neuroticism, mean (SD) 34.2 (7.7) 33.9 (7.7) 38.1 (7.1) 35.3 (7.8)
Extraversion, mean (SD) 37.6 (6.7) 38.0 (6.5) 35.9 (7.3) 36.0 (7.0)
Suicide-attempt 113 (7.2%) 89 (7.1%) 4 (9.8%) 20 (7.4%)
Dysthymia lifetime 453 (28.8%) 323 (25.6%) 13 (31.7%) 117 (43.2%)
Recurrent MDD 888 (56.5%) 712 (56.5%) 23 (56.1%) 153 (56.5%)
Chronic depression 252 (16.0%) 191 (15.1%) 5 (12.2%) 56 (20.7%)
Anxiety4 ,12 months 434 (27.6%) 324 (25.7%) 22 (53.7%) 88 (32.5%)
Anxiety4 lifetime incl. ,6 months 1070 (68.1%) 811 (64.3%) 32 (78.0%) 229 (84.5%)
Care characteristics
Contact with GP ,6 months 1232 (78.4%) 982 (77.9%) 34 (82.9%) 217 (80.1%)
No. of contacts GP ,6 months, mean (SD) 2.2 (2.5) 2.1 (2.3) 3.3 (3.6) 2.6 (3.4)
Contact GP about mental 219 (13.9%) 140 (11.1%) 24 (58.5%) 56 (20.7%)
Received information 249 (15.8%) 171 (13.6%) 20 (48.8%) 59 (21.8%)
Received referral 199 (12.7%) 128 (10.2%) 21 (51.2%) 51 (18.8%)
Received psychotherapy 346 (22.0%) 252 (20.0%) 24 (58.5%) 71 (26.2%)
Perceived need for more or other treatment 388 (24.7%) 299 (23.7%) 8 (19.5%) 78 (28.8%)
Psychological/psychiatric care past six
months5
511 (32.5%) 358 (28.4%) 33 (80.5%) 121 (44.6%)
Past antidepressant use 127 (8.1%) 100 (7.9%) 7 (17.1%) 20 (7.4%)
Benzodiazepine use 178 (11.3%) 105 (8.3%) 10 (24.4%) 63 (23.2%)
SSRI6 current 248 (15.8%) N/A 29 (70.7%) 219 (80.8%)
All numbers are number of participants with characteristic (percentage) unless otherwise specified.
In all dichotomous variables 0 = no/characteristic not present, 1 = yes/characteristic present
1Low-average (elementary (not completed), general intermediate, lower/intermediate vocational, or general secondary education) versus high (higher vocational,
college or university education).
2Inventory of depressive symptomatology; depression severity. None-mild disorder versus moderate to (very) severe disorder.
3Beck’s anxiety inventory; anxiety severity, none-mild disorder versus moderate to severe disorder.
4Anxiety disorder (panic disorder with or without agoraphobia, agoraphobia, social phobia or generalized anxiety disorder).
5Primary mental health care/psychological care: social worker, social psychiatric nurse, first line psychologist, psychotherapist; secondary mental health care/psychiatric
care: psychiatrist, professional from a mental health care organisation.
6Selective Serotonin Reuptake Inhibitors.
doi:10.1371/journal.pone.0097463.t001
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stopped. Patients with a higher education might favour psycho-
therapy instead of antidepressant treatment, or GPs might think
that patients with a lower education are less able to benefit from
psychotherapy. The fact that patients on maintenance treatment
more often use benzodiazepines is probably related to symptoms of
anxiety for which these drugs are frequently prescribed.
Patients on maintenance treatment had received more often
psychological/psychiatric care. We expected that this difference
was due to the reception of more psychiatric care, since we had
expected patients on maintenance treatment to be patients with
recurrent, chronic or more severe depression. Therefore we
performed a post-hoc analysis and found that patients on
maintenance antidepressant treatment had indeed received more
psychiatric (19.5% versus 7.3%) and not more psychological
(25.0% versus 22.5%) care. These patients could be more severely
ill and therefore have a good reason for maintenance antidepres-
sant treatment, or GPs have less insight in patients (previously)
treated in secondary mental health care but do repeat their
prescriptions as a result of which antidepressant treatment is not
critically evaluated.
The number of contacts with the GP and whether the patient
had had contact with the GP about mental problems in the last six
months were not correlated to maintenance treatment, as we
would have expected. An explanation for this could be that
Table 2. Results of bivariate multilevel logistic regression in patients remitted depression* with dependent variable ‘maintenance
treatment with antidepressants.’
Remitted patients (1571 measurements)
Odds ratio (95% CI) p-value
Sociodemographics
Age in years 1.035 (1.018–1.051) 0.000
Gender (female) 1.016 (0.685–1.507) 0.937
Education1 (high) 1.742 (1.219–2.489) 0.002
Working 0.863 (0.615–1.212) 0.395
Clinical characteristics
No. chronic somatic diseases 1.065 (0.916–1.239) 0.413
IDS2 (mod/severe) 1.293 (0.874–1.914) 0.199
BAI3 (mod/severe) 1.250 (0.779–2.004) 0.355
Neuroticism 1.015 (0.993–1.037) 0.173
Extraversion 0.965 (0.940–0.990) 0.006
Suicide attempt 1.024 (0.570–1.841) 0.936
Dysthymia lifetime 2.226 (1.537–3.223) 0.000
MDD,12 months 1.209 (0.754–1.939) 0.430
Recurrent MDD 1.043 (0.734–1.481) 0.814
Chronic depression 1.587 (1.017–2.477) 0.042
Anxiety4,12 months 1.171 (0.836–1.641) 0.358
Anxiety4 lifetime 2.910 (1.902–4.452) 0.000
Care characteristics
Contact with GP,6 months 1.129 (0.779–1.635) 0.522
No. of contacts GP,6 months 1.045 (0.987–1.106) 0.129
Contact GP about mental problems 1.411 (0.938–2.121) 0.098
Received information 1.406 (0.952–2.077) 0.087
Received referral 1.496 (0.980–2.285) 0.062
Received psychotherapy 1.232 (0.859–1.768) 0.256
Perceived need for more or other treatment 1.174 (0.833–1.654) 0.361
Psychological/psychiatric care5 1.584 (1.149–2.185) 0.005
Past antidepressant use 0.660 (0.364–1.198) 0.172
Benzodiazepine use 2.389 (1.528–3.735) 0.000
*1571 measurements in 776 individual patients.
In all dichotomous variables 0 = no/characteristic not present, 1 = yes/characteristic present.
1Low-average (elementary (not completed), general intermediate, lower/intermediate vocational, or general secondary education) versus high (higher vocational,
college or university education).
2Inventory of depressive symptomatology; depression severity. None-mild disorder versus moderate to (very) severe disorder.
3Beck’s anxiety inventory; anxiety severity, none-mild disorder versus moderate to severe disorder.
4Anxiety disorder (panic disorder with or without agoraphobia, agoraphobia, social phobia or generalized anxiety disorder).
5Primary mental health care/psychological care: social worker, social psychiatric nurse, first line psychologist, psychotherapist; secondary mental health care/psychiatric
care: psychiatrist, professional from a mental health care organisation, care in the past six months.
doi:10.1371/journal.pone.0097463.t002
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patients with a history of depression in general visit their GP
frequently and not just those on maintenance treatment with
antidepressants.
Severity (IDS) was not significant, probably since severity was
not measured at the start of the episode, but instead at
predetermined points in time during the interviews, at which time
we selected patients in remission, i.e. without current disorder and
therefore probably not a high severity score.
Strengths and limitations
The present study has several strong points. First, our study
group was large, especially for a primary care study. Second, the
data collected within NESDA is extensive, enabling us to examine
many possible determinants. Third, since the GP was unaware of
the study diagnosis, all treatment decisions were based on their
own judgment, preventing bias. Fourth, since we had several
measurements, we could quite accurately determine the time of
remission and presence of maintenance antidepressant treatment
with antidepressants.
This study also has some limitations that need addressing. First,
since variables such as depression and anxiety severity were not
measured at the start of the episode or start of the antidepressant,
we could not be sure that no relationship between severity and
maintenance treatment with antidepressants exists. Next to that,
although the CIDI was administered at three different times, we
could not be sure of the exact moment of remission and therefore
had to use a slightly less accurate definition of maintenance
treatment (treatment with antidepressants for $12 months, while
there was no depression in the past six months), because the
guideline recommends continuation treatment for all patients for
six months. In addition, we were unable to use GP diagnosis as a
predictor, since diagnosis coding was missing in a significant
(.25%) percentage of contacts with the GP, therefore we were
unable to analyse whether recognition was a significant predictor
of (maintenance) antidepressant use. This limitation also meant
that diagnosis was solely based on the interview data/the CIDI, it
could be that in some cases GP diagnosis was different from the
CIDI diagnosis. Finally, duration since last episode was not
included in the analyses. And although this was measured in
NESDA, we felt that as this was self-reported during the interviews
and many patients reported durations exceeding several years,
reliability was at best questionable. Reliability of recall of
depressive symptomatology has been questioned by several
researchers[29,30]. Therefore we decided not to test this.
Comparison with literature
Only few articles report on determinants of maintenance
treatment with antidepressants in primary care. A few researchers
did study risk factors for non-adherence to continuation and
maintenance treatment. Burton et al. studied factors associated
with the duration of antidepressant treatment, 40% of their
patients continued their antidepressant for more than 180 days.
They did not find an association between continuation and
sociodemographic factors such as age, gender and socioeconomic
deprivation. We did find an association between maintenance
treatment with antidepressants and both age and education level.
Treatment .180 days could be viewed as continuation or
maintenance treatment but is probably in most cases shorter than
our definition of maintenance treatment. It could be that the
differences arise after longer treatment [31]. Holma et al. found
several indicators of receiving maintenance treatment in the
univariate analyses: number of previous episodes, comorbid
somatic disorders and comorbid mental disorders, severity of
anxiety, anxiety disorders, positive medication attitude, personality
disorder and good adherence during the acute phase of treatment.
In their multivariate analysis only good adherence to acute phase
antidepressant treatment remained significant, we did not study
this, but did find a significant association between maintenance
treatment and anxiety disorders as they did in their univariate
analyses [32]. Finally Ten Doesschate et al. examined potential
predictors of non-adherence to continuation and maintenance
antidepressant use and found that in multivariate analysis
personality (measured with the Personality Disorder Question-
naire-4+) and a higher education were associated with an
increasing likelihood for non-adherence. A higher education
decreased likelihood of maintenance treatment in our study,
comparable to the result of ten Doesschate et al. [33]. The
Table 3. Results of multivariate multilevel logistic regression in patients with remitted depression* with dependent variable
‘‘maintenance treatment with antidepressants.’’
Odds ratio 95% CI for odds ratio p-value
Sociodemographics
Age (in years) 1.033 1.014–1.051 0.000
Education1 (high) 0.645 0.440–0.945 0.024
Clinical characteristics
Dysthymia lifetime 1.891 1.290–2.771 0.001
Anxiety lifetime2 2.300 1.474–3.589 0.000
Care characteristics
Psychological/psychiatric care past six months3 1.644 1.164–2.321 0.005
Benzodiazepine use 2.046 1.283–3.262 0.003
*1571 measurements in 776 individual patients.
In all dichotomous variables 0 = no/characteristic not present, 1 = yes/characteristic present.
1Low-average (elementary (not completed), general intermediate, lower/intermediate vocational, or general secondary education) versus high (higher vocational,
college or university education).
2Anxiety disorder (panic disorder with or without agoraphobia, agoraphobia, social phobia or generalized anxiety disorder).
3Primary mental health care/psychological care: social worker, social psychiatric nurse, first line psychologist, psychotherapist; secondary mental health care/psychiatric
care: psychiatrist, professional from a mental health care organisation.
doi:10.1371/journal.pone.0097463.t003
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personality characteristic extraversion was only significant in the
bivariate analysis in our study.
We could not find any other studies that had studied or found
dysthymia and/or benzodiazepine use to increase likelihood of
receiving maintenance treatment with antidepressants.
Comparison with guideline recommendations. As men-
tioned in the introduction, it is also interesting to compare our
results with guideline recommendations for maintenance treat-
ment. Depression guidelines, including the Dutch General
Practitioners guideline, recommend maintenance treatment with
antidepressants for patients at high risk for relapse and/or
recurrence or chronic depression. As we stated in a review in
2010, different guidelines have different indicators of patients at
high risk for chronic or recurrent course of depression [5]. The
Dutch guideline we used, used the following indicators: recurrent
or chronic depression and/or failure of non-pharmacological
treatment, or in case of residual or recurrent symptoms after
phasing out antidepressants [4]. We would expect these established
risk factors for unfavourable course to be determinants of
maintenance use.
We were very surprised to find that recurrent and chronic
depression were not more common in patients with maintenance
antidepressant treatment, since these were the two key indications
for maintenance antidepressant treatment in patients with
depression according to the Dutch General practitioners guideline
(and other guidelines). Since chronic depression was significant in
the bivariate analysis it could be that any effect was overshadowed
in the multivariate analysis by the fact that these patients e.g. more
often received psychological or psychiatric care since chronic
depression is also an indication for referral [4]. In an article about
referral of depressed patients we did indeed find that chronically
depressed patients were referred more often [34]. Recurrent
depression did not reach significance or even a trend towards
significance in the bivariate analysis. We found it difficult to
explain this unexpected finding. One explanation would be that
maintenance treatment is prescribed more often only to patients
with a high number of previous episodes instead of to all patients
with a recurrent episode. Since recall bias of number of episodes is
a problem, we decided not to analyse number of episodes. The
new Dutch GP guideline depression (2012) also recommends
reserving maintenance treatment with antidepressants for patients
with more than three episodes of depression [35].
The presence of an anxiety disorder increased likelihood of
receiving maintenance antidepressant treatment. All anxiety
disorders tested in this study are legitimate indications for the
prescription of an antidepressant and the guideline anxiety
disorders recommends to continue the antidepressant for at least
six to twelve months after remission [36]. A significant proportion
of our population probably did not use maintenance antidepres-
sant treatment for remitted depression, but instead with a good
indication for an anxiety disorder
Implications for clinical practice and future research
Not only patients with a comorbid anxiety disorder, but also
those with a history of a dysthymic disorder, older patients, lower
educated patients and those receiving psychiatric care or
benzodiazepines more often use maintenance treatment with
antidepressants and remarkably not patients with a recurrent or
chronic disorder. GPs should be aware of patients with mainte-
nance antidepressant treatment and individually weigh the risks of
stopping versus the disadvantages of continuing the drug, together
with the patient. As patients with a dysthymic disorder have a
questionable indication for antidepressant use, the dubious
advantages and more clear disadvantages of continuing should
be critically discussed in these patients. In all patients, but maybe
especially in older patients and those with a lower education, it
might be necessary for the GP to initiate the discussion about
continuation or discontinuation of antidepressant treatment, since
these patients seem to use maintenance treatment more often
while it is unclear if they have a higher risk of recurrence. Finally,
in patients referred back from secondary mental health care on
antidepressant treatment, the GP might propose a consultation
once or twice yearly, as also proposed in the recent new Dutch GP
guideline depression. This consultation could according to the new
guideline not only be used to discuss the need to continue the
antidepressant, but also to notice signs of impending relapse or
recurrence at an early stage.
The role of views of the GP has not yet been studied. It would
be interesting if a positive or negative attitude of GPs towards both
depressed patients, their views of their task in treating depression
and their views of the efficacy and place of antidepressants in
depression treatment, influences treatment with antidepressants in
their patients. It might also be interesting to study cardiovascular
risk factors or lifestyle such as smoking habits, body mass index
and use of supplements such as fish oil in order to study relation
between lifestyle and choice of treatment for MDD. Next to that,
additional analysis is needed among antidepressant users to
identify those ‘at risk’ for long-term treatment, since in our group
also non-users were present. In addition, another interesting group
to study in more detail are patients with persisting depression that
have been using an antidepressant for over a year. It would be
interesting to find out who these, in some way undertreated,
patients are and how we could help these patients to recover.
Fourth, qualitative studies in patients and GPs would be
interesting to shed more light on decision making and reasons
behind choices to (dis)continue antidepressants. Finally, it would
be very interesting to perform a randomized controlled trial in
which patients are either advised to stop or continue an
antidepressant to evaluate risk factors for recurrent/chronic
depression after (dis)continuation of antidepressants and establish
recommendations for maintenance antidepressant treatment based
on evidence.
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